CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Open-market sale Director sold 15,912 shares at $7.66 ($121,886)
- 144 Insider Sale of Securities
- 8-K Event Agreement ended · Executive or director change · Regulation FD disclosure
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 34,721,118 shares at $9.00 ($312,490,062)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 3,243,049 shares at an average $6.56 ($21,267,731)
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC TO-T Deal Tender Offer Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC TO-C Deal Written Communication Relating to an Issuer
- 10-Q Report Quarterly Report
- SC TO-C Deal Written Communication Relating to an Issuer
- 8-K Event Results of operations
- 4 Grant or award Director acquired 30,149 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,149 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 5 of 121 · 2,419 filings